Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services-Reference-Cited by-同舟云学术

Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services

Published:2020-02-24 Issue:9 Volume:115 Page:1683-1694
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Krawczyk Noa¹²^ORCID,Mojtabai Ramin²,Stuart Elizabeth A.²,Fingerhood Michael²³,Agus Deborah²,Lyons B. Casey⁴,Weiner Jonathan P.⁵,Saloner Brendan⁵^ORCID

Affiliation:

1. Department of Population Health NYU School of Medicine New York NY USA

2. Department of Mental Health Johns Hopkins Bloomberg School of Public Health Baltimore MD USA

3. Johns Hopkins School of Medicine Baltimore MD USA

4. Maryland Department of Health Office of Provider Engagement and Regulation Catonsville MD USA

5. Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore MD USA

Funder

National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.14991

Reference52 articles.

1. Drug and opioid‐involved overdose deaths—United States, 2013–2017;Scholl L.;Morb Mortal Wkly Rep,2019

2. A Public Health Strategy for the Opioid Crisis

3. Development of a Cascade of Care for responding to the opioid epidemic

4. Using Science to Battle Stigma in Addressing the Opioid Epidemic: Opioid Agonist Therapy Saves Lives

5. Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Buprenorphine treatment and clinical outcomes under the opioid use disorder cascade of care;Drug and Alcohol Dependence;2024-10

2. Implementation of medication for opioid use disorder treatment during a natural disaster: The PROUD-LA study;Journal of Substance Use and Addiction Treatment;2024-10

3. Barriers to retention in inpatient and residential drug treatment among persons who use opioids and/or injection drugs living in the rural U.S.;Journal of Substance Use and Addiction Treatment;2024-10

4. President’s message;Journal of Addictive Diseases;2024-08-23

5. Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients;Addiction;2024-08-05